المؤلفون: Kadamkulam Syriac A; Dana-Farber Cancer Institute at St. Elizabeth's Medical Center, Boston, MA, USA.; Mass General Cancer Center at Wentworth-Douglass Hospital, Dover, NH, USA., Nandu NS; University Hospital, University of Missouri Health Care, Columbia, MO, USA., Clark A; Foundation Medicine, Cambridge, MA, USA., Tavallai M; Foundation Medicine, Cambridge, MA, USA., Jin DX; Foundation Medicine, Cambridge, MA, USA., Sokol E; Foundation Medicine, Cambridge, MA, USA., McGregor K; Foundation Medicine, Cambridge, MA, USA., Ross JS; Foundation Medicine, Cambridge, MA, USA.; Upstate Medical University, Syracuse, NY, USA., Danziger N; Foundation Medicine, Cambridge, MA, USA., Leone JP; Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA. JoseP_Leone@dfci.harvard.edu.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. JoseP_Leone@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. JoseP_Leone@dfci.harvard.edu.

المصدر: Breast cancer research : BCR [Breast Cancer Res] 2024 Jul 24; Vol. 26 (1), pp. 118. Date of Electronic Publication: 2024 Jul 24.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms, Male*/genetics , Breast Neoplasms, Male*/pathology , Receptor, ErbB-2*/metabolism , Receptor, ErbB-2*/genetics , Genomics*/methods , Receptors, Estrogen*/metabolism , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Breast Neoplasms*/metabolism , Mutation*, Humans ; Female ; Male ; Middle Aged ; Biomarkers, Tumor/genetics ; Aged ; Gene Expression Profiling ; Adult ; Triple Negative Breast Neoplasms/genetics ; Triple Negative Breast Neoplasms/pathology ; Neoplasm Metastasis ; Receptors, Progesterone/metabolism ; Receptors, Progesterone/genetics ; Tumor Suppressor Protein p53/genetics ; Genetic Predisposition to Disease

المؤلفون: Lai J; Department of Oncology, GanJiang New Area Hospitalof, First Affiliated Hospital of NanChang University, NanChang, Jiangxi, 330117, People's Republic of China., Luo H; Department of Oncology, the First Affiliated Hospital of NanChang University, NanChang, Jiangxi, 330006, People's Republic of China. ndyfy01984@ncu.edu.cn., Hu S; Department of Acute Infectious Diseases, Third People's Hospital of Jiujiang City, JiuJiang Hospital of Nanchang Medical College, Jiujiang, Jiangxi, 332000, People's Republic of China., Zhong F; Jiangxi Medicine College, Nanchang University, NanChang, Jiangxi, 330006, People's Republic of China., Chen R; Department of Oncology, Jiujiang NO.1 People's Hospital, Jiujiang Water of Life Hospital, Jiujiang, Jiangxi, 332000, People's Republic of China., Lin H; Department of Oncology, the First Affiliated Hospital of NanChang University, NanChang, Jiangxi, 330006, People's Republic of China.

المصدر: Journal of the Egyptian National Cancer Institute [J Egypt Natl Canc Inst] 2024 Sep 23; Vol. 36 (1), pp. 29. Date of Electronic Publication: 2024 Sep 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: SpringerOpen Country of Publication: England NLM ID: 9424566 Publication Model: Electronic Cited Medium: Internet ISSN: 2589-0409 (Electronic) Linking ISSN: 11100362 NLM ISO Abbreviation: J Egypt Natl Canc Inst Subsets: MEDLINE

مواضيع طبية MeSH: Breath Holding* , Radiotherapy Dosage* , Radiotherapy Planning, Computer-Assisted*/methods , Unilateral Breast Neoplasms*/radiotherapy , Unilateral Breast Neoplasms*/surgery , Organs at Risk*/radiation effects, Humans ; Female ; Radiotherapy, Adjuvant/methods ; Middle Aged ; Adult ; Breast Neoplasms/radiotherapy ; Breast Neoplasms/surgery ; Mastectomy, Segmental ; Aged ; Heart/radiation effects ; Tomography, X-Ray Computed ; Lung/radiation effects ; Lung/surgery ; Inhalation

عنوان ترانسليتريتد: A metaplasztikus emlődaganat retrospektív elemzése.

المؤلفون: Kolossváry K; Mellkasi és Hasüregi Daganatok és Klinikai Farmakológiai Osztály, Országos Onkológiai Intézet, Budapest, Hungary. kolossvary.kinga@oncol.hu., Nagy R; Mellkasi és Hasüregi Daganatok és Klinikai Farmakológiai Osztály, Országos Onkológiai Intézet, Budapest, Hungary. kolossvary.kinga@oncol.hu., Papp E; Daganatpatológiai Központ, Országos Onkológiai Intézet, Budapest, Hungary., Sávolt Á; Nemzeti Tumorbiológiai Laboratórium, Országos Onkológiai Intézet, Budapest, Hungary., Tóth E; Daganatpatológiai Központ, Országos Onkológiai Intézet, Budapest, Hungary., Rubovszky G; Mellkasi és Hasüregi Daganatok és Klinikai Farmakológiai Osztály, Országos Onkológiai Intézet, Budapest, Hungary. kolossvary.kinga@oncol.hu.

المصدر: Magyar onkologia [Magy Onkol] 2024 Sep 19; Vol. 68 (3), pp. 269-275. Date of Electronic Publication: 2024 Jul 12.

نوع المنشور: English Abstract; Journal Article

بيانات الدورية: Publisher: Professional Publishing Hungary Kft Country of Publication: Hungary NLM ID: 9313833 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2060-0399 (Electronic) Linking ISSN: 00250244 NLM ISO Abbreviation: Magy Onkol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/pathology , Breast Neoplasms*/mortality , Breast Neoplasms*/therapy , Breast Neoplasms*/drug therapy , Neoadjuvant Therapy*/methods , Metaplasia*, Humans ; Female ; Retrospective Studies ; Middle Aged ; Adult ; Aged ; Prognosis ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Treatment Outcome ; Triple Negative Breast Neoplasms/pathology ; Triple Negative Breast Neoplasms/mortality ; Triple Negative Breast Neoplasms/therapy ; Triple Negative Breast Neoplasms/drug therapy ; Hungary/epidemiology ; Palliative Care ; Neoplasm Staging ; Chemotherapy, Adjuvant

المؤلفون: Wu F; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China.; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian Province, China., Li N; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China., Wu X; Department of Breast Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China., Chen M; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China., Huang W; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China.; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian Province, China., Chen X; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China., Hong Y; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China., Wang L; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China., Chen K; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China., Lin L; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China., You M; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China., Liu J; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China. liujianfj@126.com.

المصدر: BMC cancer [BMC Cancer] 2024 Sep 19; Vol. 24 (1), pp. 1166. Date of Electronic Publication: 2024 Sep 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Enhancer of Zeste Homolog 2 Protein*/genetics , Enhancer of Zeste Homolog 2 Protein*/metabolism , Apoptosis*/genetics , Mutation* , Cell Proliferation*/genetics , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Neoplasm Invasiveness*, Humans ; Female ; Middle Aged ; Prognosis ; Cell Line, Tumor ; Adult ; Aged ; Biomarkers, Tumor/genetics ; Cell Movement/genetics ; Triple Negative Breast Neoplasms/genetics ; Triple Negative Breast Neoplasms/pathology

المؤلفون: Górnicki T; Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, T. Chalubinskiego 6a St., 50-368 Wroclaw, Poland., Lambrinow J; Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, T. Chalubinskiego 6a St., 50-368 Wroclaw, Poland., Mrozowska M; Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, T. Chalubinskiego 6a St., 50-368 Wroclaw, Poland., Krawczyńska K; Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, T. Chalubinskiego 6a St., 50-368 Wroclaw, Poland., Staszko N; Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, T. Chalubinskiego 6a St., 50-368 Wroclaw, Poland., Kmiecik A; Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, T. Chalubinskiego 6a St., 50-368 Wroclaw, Poland., Piotrowska A; Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, T. Chalubinskiego 6a St., 50-368 Wroclaw, Poland., Gomułkiewicz A; Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, T. Chalubinskiego 6a St., 50-368 Wroclaw, Poland., Romanowicz H; Laboratory of Cancer Genetics, Department of Pathology, Polish Mother's Memorial Hospital Research Institute, Rzgowska 281/289, 93-338 Lodz, Poland., Smolarz B; Laboratory of Cancer Genetics, Department of Pathology, Polish Mother's Memorial Hospital Research Institute, Rzgowska 281/289, 93-338 Lodz, Poland., Podhorska-Okołów M; Division of Ultrastructure Research, Department of Human Morphology and Embryology, Wroclaw Medical University, T. Chalubinskiego 6a St., 50-368 Wroclaw, Poland., Grzegrzółka J; Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, T. Chalubinskiego 6a St., 50-368 Wroclaw, Poland., Rusak A; Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, T. Chalubinskiego 6a St., 50-368 Wroclaw, Poland., Dzięgiel P; Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, T. Chalubinskiego 6a St., 50-368 Wroclaw, Poland.

المصدر: Cells [Cells] 2024 Sep 14; Vol. 13 (18). Date of Electronic Publication: 2024 Sep 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

مواضيع طبية MeSH: Epithelial-Mesenchymal Transition*/genetics , RNA-Binding Proteins*/metabolism , RNA-Binding Proteins*/genetics , Triple Negative Breast Neoplasms*/genetics , Triple Negative Breast Neoplasms*/pathology , Triple Negative Breast Neoplasms*/metabolism, Humans ; Female ; Cell Line, Tumor ; Biomarkers, Tumor/metabolism ; Biomarkers, Tumor/genetics ; Gene Expression Regulation, Neoplastic ; Cell Movement/genetics ; Middle Aged ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Breast Neoplasms/metabolism ; Disease Progression

المؤلفون: Sun X; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Kennedy LC; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee., Gonzalez-Ericsson PI; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee., Sanchez V; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Sanders M; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee., Perou CM; Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina., Troester MA; Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina., Balko JM; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee., Reid SA; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 13; Vol. 30 (18), pp. 4077-4081.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor*/genetics , Triple Negative Breast Neoplasms*/genetics , Triple Negative Breast Neoplasms*/immunology , Triple Negative Breast Neoplasms*/pathology, Humans ; Female ; Middle Aged ; Aged ; Adult ; Histocompatibility Antigens Class II/genetics ; Histocompatibility Antigens Class I/genetics ; Histocompatibility Antigens Class I/metabolism ; Histocompatibility Antigens Class I/immunology ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Breast Neoplasms/immunology ; Prognosis ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Immunotherapy/methods

المؤلفون: Kong C; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Pathology, Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China., Yu B; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Institute of Pathology, Fudan University, Shanghai, 200032, China., Bi R; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Institute of Pathology, Fudan University, Shanghai, 200032, China., Xu X; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Institute of Pathology, Fudan University, Shanghai, 200032, China., Cheng Y; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Institute of Pathology, Fudan University, Shanghai, 200032, China., Yang W; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Institute of Pathology, Fudan University, Shanghai, 200032, China., Shui R; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. shuiruohong2014@163.com.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. shuiruohong2014@163.com.; Institute of Pathology, Fudan University, Shanghai, 200032, China. shuiruohong2014@163.com.

المصدر: Diagnostic pathology [Diagn Pathol] 2024 Sep 06; Vol. 19 (1), pp. 121. Date of Electronic Publication: 2024 Sep 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101251558 Publication Model: Electronic Cited Medium: Internet ISSN: 1746-1596 (Electronic) Linking ISSN: 17461596 NLM ISO Abbreviation: Diagn Pathol Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor*/analysis , Triple Negative Breast Neoplasms*/pathology , Triple Negative Breast Neoplasms*/genetics , Repressor Proteins*/analysis , DNA-Binding Proteins*/analysis , DNA-Binding Proteins*/metabolism , Transcription Factors*/analysis , Receptors, Androgen*/analysis , Receptors, Androgen*/genetics, Humans ; Female ; Immunohistochemistry ; Middle Aged ; Breast Neoplasms/pathology ; Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Adult

المؤلفون: Lee H; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Cho YA; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Kim DG; Department of Digital Health, Samsung Advanced Institute of Health Science and Technology, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Department of Clinical Genomic Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Son JY; Pathology Center, Busan and Gyeongnam Laboratory Center, Seegene Medical Foundation, Busan, Republic of Korea., Cho EY; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; eunyoon.cho@samsung.com.

المصدر: Anticancer research [Anticancer Res] 2024 Sep; Vol. 44 (9), pp. 3983-3994.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Suppressor Protein p53*/genetics , Tumor Suppressor Protein p53*/metabolism , High-Throughput Nucleotide Sequencing* , Immunohistochemistry* , Mutation* , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Breast Neoplasms*/drug therapy , Breast Neoplasms*/metabolism , Breast Neoplasms*/mortality, Humans ; Female ; Middle Aged ; Adult ; Aged ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; DNA Mutational Analysis ; Prognosis ; Triple Negative Breast Neoplasms/genetics ; Triple Negative Breast Neoplasms/pathology ; Triple Negative Breast Neoplasms/drug therapy

المؤلفون: Grasset EM; Université de Nantes, INSERM, CNRS, CRCI2NA, Nantes, France. Eloise.grasset@inserm.fr.; Équipe Labellisée LIGUE Contre le Cancer CRCI2NA, Nantes, France. Eloise.grasset@inserm.fr.; Department of Cell Biology, Johns Hopkins University, School of Medicine, Baltimore, MD, USA. Eloise.grasset@inserm.fr., Deshpande A; Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.; Convergence Institute, Johns Hopkins University, Baltimore, MD, USA.; Department of Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD, USA., Lee JW; Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.; Department of Pathology, Johns Hopkins University, School of Medicine, Baltimore, MD, USA., Cho Y; Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA., Shin SM; Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA., Coyne EM; Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA., Hernandez A; Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA., Yuan X; Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA., Zhang Z; Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA., Cimino-Mathews A; Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.; Department of Pathology, Johns Hopkins University, School of Medicine, Baltimore, MD, USA., Ewald AJ; Department of Cell Biology, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.; Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.; Convergence Institute, Johns Hopkins University, Baltimore, MD, USA.; Giovanis Institute for Translational Cell Biology, Johns Hopkins University, School of Medicine, Baltimore, MD, USA., Ho WJ; Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA. wjho@jhmi.edu.; Convergence Institute, Johns Hopkins University, Baltimore, MD, USA. wjho@jhmi.edu.

المصدر: Oncogene [Oncogene] 2024 Sep; Vol. 43 (39), pp. 2927-2937. Date of Electronic Publication: 2024 Aug 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Microenvironment* , Triple Negative Breast Neoplasms*/pathology , Triple Negative Breast Neoplasms*/metabolism , Macrophages*/pathology , Macrophages*/metabolism , Macrophages*/immunology, Humans ; Female ; Neoplastic Stem Cells/pathology ; Neoplastic Stem Cells/metabolism ; Neoplasm Metastasis ; Cell Line, Tumor ; Vimentin/metabolism ; Breast Neoplasms/pathology ; Breast Neoplasms/metabolism

المؤلفون: Bischoff H; Medical Oncology Department, Institut de Cancérologie Strasbourg Europe, ICANS, 17 Rue Albert Calmette, 67033, Strasbourg, France. h.bischoff@icans.eu., Espié M; Medical Oncology Department, Hôpital Saint Louis, Paris, France., Petit T; Medical Oncology Department, Institut de Cancérologie Strasbourg Europe, ICANS, 17 Rue Albert Calmette, 67033, Strasbourg, France.

المصدر: Current treatment options in oncology [Curr Treat Options Oncol] 2024 Sep; Vol. 25 (9), pp. 1210-1224. Date of Electronic Publication: 2024 Aug 15.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Neoadjuvant Therapy*/methods , Triple Negative Breast Neoplasms*/therapy , Triple Negative Breast Neoplasms*/drug therapy , Receptor, ErbB-2*/metabolism , Receptor, ErbB-2*/antagonists & inhibitors , Receptors, Estrogen*/metabolism, Humans ; Female ; Biomarkers, Tumor ; Breast Neoplasms/therapy ; Breast Neoplasms/drug therapy ; Breast Neoplasms/metabolism ; Neoplasm Staging ; Disease Management ; Combined Modality Therapy/methods ; Combined Modality Therapy/adverse effects ; Treatment Outcome ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Molecular Targeted Therapy/methods